China China China

China Updates: Doubling down on the Dynamic Zero-COVID policy

Macro 5 minutes to read
Redmond Wong

Market Strategist, Greater China

Summary:  China reasserts its adherence to the Dynamic Zero Covid policy yesterday. The Standing Committee of the Chinese Communist Party calls for national mobilization to fight against COVID-19 and warns against narratives that “doubt, question, or dismiss” the country’s pandemic control measures. Prior reference to minimizing socioeconomic costs of pandemic control is replaced by emphasizing duties and fulfilling basic livelihood.


The Standing Committee of the Chinese Communist Party’s Politburo  (the Standing Committee) doubled down on the Dynamic Zero-COVID policy in a meeting on May 5, 2022.  The meeting, which President Xi Jinping chaired, asserts China’s unswerving adherence to the Dynamic Zero Covid policy.  The Standing Committee commands party cadres, government officials, and community leaders at all levels to unite themselves in thinking and actions close to the centre of the Chinese Communis Party (the Party) and not to waver in pandemic control.  In the view of the Standing Committee, China’s pandemic control policy is a matter of the nature  and principle of the Party. 

Resemblance of war-time mobilization. The Standing Committee urges party cadres and government officials to speed up and extend the scope of pandemic control measures and tighten control and coordination.  It is worth to note that the remark by the Standing Committee on a prior meeting on March 17, 2022 that “more effective measures should be taken to achieve maximum effect in prevention and control with minimum cost, and to reduce the impact on socioeconomic development as much as possible” is missing this time and replaced by the bare minimum reference to “protecting people’s basic livelihood and supplies of daily necessities and their need for medical care”.  society against the Dynamic Zero Covid policy. 

The Standing Committee calls on comprehensive mobilization throughout the party, the government and the society to earnestly enforce pandemic control.  It emphasizes that it is a duty of not only party cadres and government officials but also industries, corporate and individuals to do their parts well in the war against the pandemic. Throughout the press release, the tone resembles a war time mobilisation which calls for unity, determination, and sacrifices. In other words, the economic costs and the risk of sharply lower economic growth are all secondary to the priority of the Dynamic Zero-COVID policy. 

Putting down the pushback against Dynamic Zero-COVID policy.  The Standing Committee urges party cadres and government officials to overcome “inadequate understanding, lacking preparedness, insufficient work, complacency, indifference, self-righteousness, feeling of exhaustion, tiring of fighting, leaving things to luck and sloppiness”.  It vows to fight against narratives that “distort, question, or dismiss” China’s Dynamic Zero-COVID policy.  This warning seems aiming at putting down the emergent voice of discontents from some corners of the society, including some from social elites, against the lockdowns and other stringent controlling measures. 

Stimulus initiatives are pushing on a string. Relaxation of Dynamic Zero-COVID policy is now completely off-the-table.  The Standing Committee’s decision and subsequent statement puts an end to the any emergent debate in the society or even among certain ranks and files of the government about the enormous costs of persistent and pervasive pandemic control measures.  This is going to have enormous negative impact on the economy and the financial markets.  The much talked about economic, fiscal and monetary stimulus policy initiatives, even having been rolled out, will be just pushing on a string.

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.